News Preview
Verastem, Inc. (VSTM) Discusses New Clinical Data for VS-7375 KRAS G12D Inhibitor in Pancreatic, Lung, and Colorectal Cancers - Slideshow
Verastem, Inc. presented new clinical data for its VS-7375 KRAS G12D inhibitor in pancreatic, lung, and colorectal cancers. The company's shares are up following the presentation.
Want to stay up to date with the world events at sea or at home?
Explore Navvyx News - the best News app for seafarers.